Long-term objective compliance with a mandibular advancement device and continuous positive airway pressure in moderate obstructive sleep apnea
GE De Vries, A Hoekema, J Claessen, C Stellingsma… - 2018
Background: Comparable effectiveness of mandibular advancement device (MAD)
with continuous positive airway pressure (CPAP) therapy has been attributed to a
higher compliance with MAD when compared with CPAP. However, a direct …
with continuous positive airway pressure (CPAP) therapy has been attributed to a
higher compliance with MAD when compared with CPAP. However, a direct …
 |  |
Young obstructive sleep apnea patients: characteristics, adherence and hospitalizations tendencies
ER Jimeno, ML Flores, VG González, Z Ji, SL Martín… - 2018
Aim and objective: To describe the population of young patients (≤ 40 years)
diagnosed of obstructive sleep apnea (OSA), their adherence to CPAP and
hospitalizations of any cause, and compare them with older patients. Methods …
diagnosed of obstructive sleep apnea (OSA), their adherence to CPAP and
hospitalizations of any cause, and compare them with older patients. Methods …
| |
Independent association between obstructive sleep apnea severity and liver stiffness
W Trzepizur, J Boursier, M Le Vaillant, PH Ducluzeau… - 2018
Background and Aims: Obstructive sleep apnea (OSA) and nonalcoholic fatty liver
disease (NAFLD) are frequently encountered in overweight and obese patients.
Several data suggest that OSA per se could be a risk factor of liver injury. Most …
disease (NAFLD) are frequently encountered in overweight and obese patients.
Several data suggest that OSA per se could be a risk factor of liver injury. Most …
| |
Solriamfetol for the treatment of excessive sleepiness in obstructive sleep apnea: A placebo-controlled randomized-withdrawal study
PJ Strollo Jr, J Hedner, N Collop, DG Lorch Jr, D Chen… - Chest, 2018
Background Excessive sleepiness is a common symptom of obstructive sleep apnea
(OSA), which often persists despite primary OSA therapy. This phase 3 randomized-
withdrawal trial evaluated solriamfetol (JZP-110) for the treatment of excessive …
(OSA), which often persists despite primary OSA therapy. This phase 3 randomized-
withdrawal trial evaluated solriamfetol (JZP-110) for the treatment of excessive …
| |
Diagnosis of left ventricular diastolic dysfunction among obstructive sleep apnea patients
MC Yong, DHP Foo, SS Kho, SK Chan, AYY Fong… - 2018
Introduction: Obstructive sleep apnea (OSA) is a known risk factor for cardiovascular
mortality and morbidity. Patients with OSA can present with clinical syndromes of
heart failure, but most of them have preserved left ventricular ejection fraction …
mortality and morbidity. Patients with OSA can present with clinical syndromes of
heart failure, but most of them have preserved left ventricular ejection fraction …
| |
… Abstract-Differential effect of intermittent hypoxia and sleep fragmentation in the progression of Alzheimer Disease in a mouse model of obstructive sleep apnea
I Almendros, MJ Menal, D Gozal, A Colell, R Farré - 2018
Introduction: Increasing clinical studies suggest a potential link between obstructive
sleep apnea (OSA) and Alzheimer's disease (AD). However, the specific role of
intermittent hypoxia (IH) and sleep fragmentation (SF), the two main hallmarks of …
sleep apnea (OSA) and Alzheimer's disease (AD). However, the specific role of
intermittent hypoxia (IH) and sleep fragmentation (SF), the two main hallmarks of …
| |
The Relation Between Cardiovascular Diseases And Antropometric Measurements In Patients With Obstructive Sleep Apnea: A Single Center Study
A Kanbay, Hİ Yakar, SA Ecder, E Ceylan - 2018
The most common common risk factor for the development of Obstructive sleep
apnoea (OSA) and cardiovascular disease (CVD) is central obesity. The neck
circumference, waist circumference, waist/hip ratio, body mass index (BMI) and the 'A …
apnoea (OSA) and cardiovascular disease (CVD) is central obesity. The neck
circumference, waist circumference, waist/hip ratio, body mass index (BMI) and the 'A …
| |
The role of inflammatory biomarkers in obstructive sleep apnea syndrome
S Yilmaz, HS Sen, M Taylan, M Demir, F Topcu… - 2018
Background: Obstructive sleep apnea syndrome (OSAS) is a disease characterized
by recurrent collapse of the upper respiratory tract and chronic intermittent hypoxia,
oxidative stress, local and systemic inflammation. Methods: 195 patients with …
by recurrent collapse of the upper respiratory tract and chronic intermittent hypoxia,
oxidative stress, local and systemic inflammation. Methods: 195 patients with …
| |
Obstructive sleep apnea during REM sleep and daytime cerebral functioning: A regional cerebral blood flow study using high-resolution SPECT
AA Baril, K Gagnon, P Brayet, J Montplaisir, J Carrier… - Journal of Cerebral Blood …, 2018
Obstructive sleep apnea (OSA) predominantly during rapid eye movement (REM)
sleep may have impacts on brain health, even in milder OSA cases. Here, we
evaluated whether REM sleep OSA is associated with abnormal daytime cerebral …
sleep may have impacts on brain health, even in milder OSA cases. Here, we
evaluated whether REM sleep OSA is associated with abnormal daytime cerebral …
| |
Systematic coronary risk evaluation among obstructive sleep apnea patients
A Kania, G Bochenek, P Nastalek… - 2018
Background: Obstructive sleep apnea (OSA) is a public health hazard.
Cardiovascular morbidity is the most influenced on OSA patient's prognosis. The
systematic coronary risk evaluation (SCORE) model predicts ten-year risk of …
Cardiovascular morbidity is the most influenced on OSA patient's prognosis. The
systematic coronary risk evaluation (SCORE) model predicts ten-year risk of …
| |
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου